サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722985

初期毒性試験の市場規模、シェア、動向、予測：技法別、エンドユーザー別、地域別、2025年～2033年

Early Toxicity Testing Market Size, Share, Trends and Forecast by Technique, End User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
初期毒性試験の市場規模、シェア、動向、予測：技法別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

初期毒性試験の世界市場規模は2024年に13億7,000万米ドルとなりました。今後、IMARC Groupは、市場は2033年までに25億7,000万米ドルに達し、2025年から2033年にかけて6.84%のCAGRを示すと予測しています。現在、欧州が市場を独占しており、2024年の市場シェアは34.0%を超えます。同市場は、医薬品開発活動の活発化、規制要件の厳格化、代替検査法の進歩などを背景に大きく成長しています。予測毒性学ソリューションや動物実験の削減に対する需要の高まりが市場成長をさらに促進し、初期毒性試験の市場シェアの拡大に寄与しています。

新規化合物の初期毒性試験は、医薬品の開発や既存分子の治療可能性の拡大に用いられます。様々な生物学的系を用いた前臨床段階で実施され、製品の生物種、器官、用量特異的な毒性効果を調査します。動物を用いたin vivo、アッセイを用いた実験室でのin vitro、コンピューター上でのin silicoなど、さまざまな方法で実施されます。また、物質への偶発的な暴露の研究にも活用されています。現在では、新薬候補の後期段階での失敗が高コストに影響するため、製薬会社は治験薬で初期毒性試験を実施するようになっています。

初期毒性試験の市場動向：

有害化学物質への曝露は、皮膚接触、経口摂取、吸入によって起こる。そのため、初期毒性試験は、様々な産業用途において、製品の毒性の程度を判定し、人間の消費と環境に対する安全性を確保するための重要なプロセスとなっています。例えば、飲食品（F&B）業界では、製品に含まれる潜在的な毒性物質を特定し、その有害性を評価するために広く利用されています。さらに、疾病の増加や新規医薬品・生物学的製剤の必要性が、臨床試験における候補医薬品の失敗を防ぐために初期毒性試験採用を促しています。さらに、規制当局が課す公衆衛生に関する厳しい規制が、規制当局の承認に必要な医薬品の実行可能性を判断するための初期毒性試験の需要にプラスの影響を与えています。これとは別に、農薬の使用量の増加は人間の健康にリスクをもたらす可能性があり、農業産業における初期毒性試験の使用を促進しています。さらに、化粧品への需要の高まりは、化粧品原料の初期毒性試験の用途を世界的に拡大しています。

本レポートで扱う主な質問

  • 初期毒性試験の市場の規模は？
  • 初期毒性試験の市場の将来展望は？
  • 初期毒性試験の市場を牽引する主要因は何か？
  • 初期毒性試験の市場で最大のシェアを占める地域は？
  • 世界の初期毒性試験の市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の初期毒性試験市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：技法別

  • In vivo
  • In vitro
  • シミュレーション

第7章 市場内訳：エンドユーザー別

  • 製薬業界
  • 食品業界
  • 化学産業
  • 化粧品業界
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Charles River Laboratories International Inc.
    • Danaher Corporation
    • Enzo Biochem Inc.
    • Eurofins Scientific SE
    • Evotec A.G.
    • Merck KGaA
    • PerkinElmer Inc.
    • SGS S.A.
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec
図表

List of Figures

  • Figure 1: Global: Early Toxicity Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Early Toxicity Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Early Toxicity Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Early Toxicity Testing Market: Breakup by Technique (in %), 2024
  • Figure 5: Global: Early Toxicity Testing Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Early Toxicity Testing Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Early Toxicity Testing (In Vivo) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Early Toxicity Testing (In Vivo) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Early Toxicity Testing (In Vitro) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Early Toxicity Testing (In Vitro) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Early Toxicity Testing (In Silico) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Early Toxicity Testing (In Silico) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Early Toxicity Testing (Food Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Early Toxicity Testing (Food Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Early Toxicity Testing (Chemicals Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Early Toxicity Testing (Chemicals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Early Toxicity Testing (Cosmetics Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Early Toxicity Testing (Cosmetics Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Early Toxicity Testing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Early Toxicity Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia-Pacific: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia-Pacific: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Early Toxicity Testing Market: Breakup by Country (in %), 2024
  • Figure 71: Middle East and Africa: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Global: Early Toxicity Testing Industry: SWOT Analysis
  • Figure 73: Global: Early Toxicity Testing Industry: Value Chain Analysis
  • Figure 74: Global: Early Toxicity Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Early Toxicity Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Early Toxicity Testing Market Forecast: Breakup by Technique (in Million USD), 2025-2033
  • Table 3: Global: Early Toxicity Testing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Early Toxicity Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Early Toxicity Testing Market: Competitive Structure
  • Table 6: Global: Early Toxicity Testing Market: Key Players
目次
Product Code: SR112025A5651

The global early toxicity testing market size was valued at USD 1.37 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 2.57 Billion by 2033, exhibiting a CAGR of 6.84% from 2025-2033. Europe currently dominates the market, holding a market share of over 34.0% in 2024. The market is experiencing significant growth driven by increasing drug development activities, stringent regulatory requirements, and advancements in alternative testing methods. Growing demand for predictive toxicology solutions and reduced animal testing further fuels market growth, contributing to the expanding early toxicity testing market share.

Early toxicity testing of new compounds is used to develop drugs and the extension of the therapeutic potential of existing molecules. It is carried out at pre-clinical stages on various biological systems to investigate the species, organs, and dose-specific toxic effects of a product. It can be performed in multiple ways, including in vivo on animals, in vitro in laboratories using assays, and in silico on a computer. It is also utilized for studying accidental exposures to a substance. Nowadays, the high-cost impact of late-stage failures of drug candidates is encouraging pharma companies to conduct early toxicity testing on investigational products.

Early Toxicity Testing Market Trends:

Exposure to toxic chemicals occurs through skin contact, oral intake, or inhalation. Therefore, early toxicity testing has become a crucial process in various industrial applications for determining the degree of toxicity in products and ensuring that they are safe for human consumption and the environment. For example, it is extensively utilized in the food and beverage (F&B) industry to identify the adverse effects and characterize potential toxicants in products. Moreover, the rising prevalence of diseases and the requirement of novel drugs and biological products are encouraging the adoption of early toxicity testing to prevent the failure of candidate drugs at clinical trials. In addition, stringent regulations relating to public health welfare imposed by regulatory authorities are positively influencing the demand for early toxicity testing to determine the viability of drugs required for regulatory approval. Apart from this, the increasing usage of pesticides can pose risks to human health, which is promoting the use of early toxicity testing in the agriculture industry. Furthermore, the escalating demand for cosmetic products is expanding the application of early toxicity testing of cosmetic ingredients worldwide.

Key Market Segmentation:

Breakup by Technique:

  • In Vivo
  • In Vitro
  • In Silico

Breakup by End User:

  • Pharmaceuticals Industry
  • Food Industry
  • Chemicals Industry
  • Cosmetics Industry
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, Evotec A.G., Merck KGaA, PerkinElmer Inc., SGS S.A., Thermo Fisher Scientific Inc. and WuXi AppTec.

Key Questions Answered in This Report

  • 1.How big is the early toxicity testing market?
  • 2.What is the future outlook of early toxicity testing market?
  • 3.What are the key factors driving the early toxicity testing market?
  • 4.Which region accounts for the largest early toxicity testing market share?
  • 5.Which are the leading companies in the global early toxicity testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Early Toxicity Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technique

  • 6.1 In Vivo
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 In Vitro
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 In Silico
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Pharmaceuticals Industry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Food Industry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Chemicals Industry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cosmetics Industry
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bio-Rad Laboratories Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bruker Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Charles River Laboratories International Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Enzo Biochem Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Eurofins Scientific SE
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Evotec A.G.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Merck KGaA
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 PerkinElmer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 SGS S.A.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 WuXi AppTec
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials